CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer

Cytokine

Volumn 55, Issue 2, 2011, Pages 266-273

  Chen, Bo ^a   Zhou, Yong ^a   Yang, Ping ^a   Liu, Liu ^b   Qin, Xian Peng ^a   Wu, Xiao Ting ^a  

^a SICHUAN UNIVERSITY   (China)

^b Second Affiliated Hospital of Nan Chang University   (China)

Author keywords

CDH1; E cadherin; Gastric cancer; Gene polymorphism; Meta analysis

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; THREONINE; UVOMORULIN;

ARTICLE; ASIAN; CANCER CLASSIFICATION; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ALLELES; CADHERINS; CASE-CONTROL STUDIES; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 79959551167     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.04.008     Document Type: Article

References (49)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002, CA. Cancer J Clin 2005, 55:74-108.
2. Wang H., Zhou Y., Zhuang W., Yin Y.Q., Liu G.J., Wu T.X., et al. Glutathione S-transferase M1 null genotype associated with gastric cancer among Asians. Dig Dis Sci 2010, 55:1824-1830.
3. Chen X.Z., Jiang K., Hu J.K., Zhang B., Gou H.F., Yang K., et al. Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. World J Gastroenterol 2008, 14:2715-2722.
4. Krejs G.J. Gastric cancer: epidemiology and risk factors. Dig Dis 2010, 28:600-603.
5. Gianfagna F., De Feo E., van Duijn C.M., Ricciardi G., Boccia S. A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk. Curr Genomics 2008, 9:361-374.
6. Hamilton J.P., Meltzer S.J. A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol 2006, 4:416-425.
7. Chen B., Zhou Y., Yang P., Wu X.T. Glutathione S-transferase M1 gene polymorphism and gastric cancer risk: an updated analysis. Arch Med Res 2010, 41:558-566.
8. Kangelaris K.N., Gruber S.B. Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer. JAMA 2007, 297:2410-2411.
9. Al-Moundhri M.S., Al-Khanbashi M., Al-Kindi M., Al-Nabhani M., Burney I.A., Al-Farsi A., et al. Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J Gastroenterol 2010, 16:3432-3436.
10. Gao L., Nieters A., Brenner H. Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment Pharmacol Ther 2008, 28:565-573.
11. Wang L., Zhang F., Wu P.P., Jiang X.C., Zheng L., Yu Y.Y. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma. World J Gastroenterol 2006, 12:4228-4231.
12. Cavallaro U., Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 2001, 1552:39-45.
13. Medina-Franco H., Ramos-De la Medina A., Vizcaino G., Medina-Franco J.L. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population. Ann Surg Oncol 2007, 14:2246-2249.
14. Shin Y., Kim I.J., Kang H.C., Park J.H., Park H.R., Park H.W., et al. The E-cadherin -347G->GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 2004, 25:895-899.
15. Yamada H., Shinmura K., Ikeda S., Tao H., Otani T., Hanaoka T., et al. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand J Gastroenterol 2007, 42:1479-1485.
16. Zhou Y., Li N., Zhuang W., Yin Y.Q., Liu G.J., Wu T.X., et al. Glutathione S-transferase P1 gene polymorphism associated with gastric cancer among Caucasians. Eur J Cancer 2009, 45:1438-1442.
17. Bax L., Ikeda N., Fukui N., Yaju Y., Tsuruta H., Moons K.G. More than numbers: the power of graphs in meta-analysis. Am J Epidemiol 2009, 169:249-255.
18. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
19. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
20. Borges Bdo N., Santos Eda S., Bastos C.E., Pinto L.C., Anselmo N.P., Quaresma J.A., et al. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil. Anticancer Res 2010, 30:2225-2233.
21. Corso G., Berardi A., Marrelli D., Pedrazzani C., Garosi L., Pinto E., et al. CDH1 C-160A promoter polymorphism and gastric cancer risk. Eur J Cancer Prev 2009, 18:46-49.
22. Jenab M., McKay J.D., Ferrari P., Biessy C., Laing S., Munar G.M., et al. CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the european prospective investigation into cancer and nutrition (EPIC-EURGAST). Eur J Cancer 2008, 44:774-780.
23. Zhang B., Pan K., Liu Z., Zhou J., Lu L., Ji J., et al. Genetic polymorphisms of the E-cadherin promoter and risk of sporadic gastric carcinoma in Chinese populations. Cancer Epidemiol Biomarkers Prev 2008, 17:2402-2408.
24. Zhang X.F., Wang Y.M., Ge H., Cao Y.Y., Chen Z.F., Wen D.G., et al. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus 2008, 21:21-29.
25. Cattaneo F., Venesio T., Molatore S., Russo A., Fiocca R., Frattini M., et al. Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk. Anticancer Res 2006, 26:4627-4632.
26. Lu Y., Xu Y.C., Shen J., Yu R.B., Niu J.Y., Guo J.T., et al. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 2005, 11:56-60.
27. Song C.G., Huang C.M., Liu X., Lu H.S., Zhang X.F., Huang W. Association of -160(C->A) polymorphism in CDH1 gene with gastric cancer risk in Fujian Chinese population. Zhonghua Yi Xue Yi Chuan Xue. Za Zhi 2005, 22:557-559.
28. Kuraoka K., Oue N., Yokozaki H., Kitadai Y., Ito R., Nakayama H., et al. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol 2003, 23:421-427.
29. Park W.S., Cho Y.G., Park J.Y., Kim C.J., Lee J.H., Kim H.S., et al. A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003, 18:501-504.
30. Humar B., Graziano F., Cascinu S., Catalano V., Ruzzo A.M., Magnani M., et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002, 21:8192-8195.
31. Pharoah P.D., Oliveira C., Machado J.C., Keller G., Vogelsang H., Laux H., et al. CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer. Int J Cancer 2002, 101:196-197.
32. Wu M.S., Huang S.P., Chang Y.T., Lin M.T., Shun C.T., Chang M.C., et al. Association of the -160 C-> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 2002, 94:1443-1448.
33. Wroblewski L.E., Peek R.M., Wilson K.T. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010, 23:713-739.
34. Chen B., Cao L., Zhou Y., Yang P., Wan H.W., Jia G.Q., et al. Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies. Dig Dis Sci 2010, 55:1831-1838.
35. Liu L., Zhuang W., Wang C., Chen Z., Wu X.T., Zhou Y. Interleukin-8-251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies. Cytokine 2010, 50:328-334.
36. Zhou Y., Hu W., Zhuang W., Wu X. Interleukin-10-1082 promoter polymorphism and gastric cancer risk in a Chinese Han population. Mol Cell Biochem 2011, 347:89-93.
37. Boccia S., La Torre G., Gianfagna F., Mannocci A., Ricciardi G. Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis 2006, 21:115-123.
38. Schrader K., Huntsman D. Hereditary diffuse gastric cancer. Cancer Treat Res 2010, 155:33-63.
39. Katoh M. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 2007, 6:832-839.
40. Li L.C., Chui R.M., Sasaki M., Nakajima K., Perinchery G., Au H.C., et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000, 60:873-876.
41. Wang H.D., Ren J., Zhang L. CDH1 germline mutation in hereditary gastric carcinoma. World J Gastroenterol 2004, 10:3088-3093.
42. Wang Q, Gu D, Wang M, Zhang Z, Tang J, Chen J. The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans, DNA. Cell Biol 2011. doi:10.1089/dna.2010.1091.
43. Wang G.Y., Lu C.Q., Zhang R.M., Hu X.H., Luo Z.W. The E-cadherin gene polymorphism 160C->A and cancer risk: a HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol 2008, 167:7-14.
44. Zheng J., Yu X., Jiang L., Xiao M., Bai B., Lu J., et al. Association between the Cytotoxic T-lymphocyte antigen 4 +49G>A polymorphism and cancer risk: a meta-analysis. BMC Cancer 2010, 10:522.
45. Loh M., Koh K.X., Yeo B.H., Song C.M., Chia K.S., Zhu F., et al. Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 2009, 45:2562-2568.
46. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004, 96:434-442.
47. Becker K.F., Reich U., Schott C., Höfler H. Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 1995, 96:739-740.
48. Jiang Z., Li C., Xu Y., Cai S. A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk. Int J Colorectal Dis 2010, 25:169-180.
49. Norppa H. Genetic susceptibility, biomarker response, and cancer. Mutat Res 2003, 544:339-348.